The Current Ratio as of December 2025 (TTM) for Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) is 4.28

According to Zhejiang Orient Gene Biotech Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 4.28. This represents a change of 8.06% compared to the average of 3.96 of the last 4 quarters.

Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) Historical Current Ratio (quarterly & annually)

How has 688298.SS Current Ratio performed in the past?

The mean historical Current Ratio of Zhejiang Orient Gene Biotech Co., Ltd. over the last ten years is 3.01. The current 4.28 Current Ratio has changed 14.10% with respect to the historical average. Over the past ten years (40 quarters), 688298.SS's Current Ratio was at its highest in in the September 2023 quarter at 7.90. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Zhejiang Orient Gene Biotech Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) Average Current Ratio

How has 688298.SS Current Ratio performed in the past?

The current Current Ratio of Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) Current Ratio vs. Peers

How is 688298.SS’s Current Ratio compared to its peers?

Zhejiang Orient Gene Biotech Co., Ltd.’s Current Ratio is greater than Shanghai Kehua Bio-Engineering Co.,Ltd (2.21), greater than Getein Biotech, Inc (2.32), less than Nanjing Vishee Medical Technology Co., Ltd (6.82), less than Beijing Leadman Biochemistry Co.,Ltd. (15.03), less than Shanghai Kinetic Medical Co., Ltd (4.57), greater than Beijing Bohui Innovation Biotechnology Group Co., Ltd. (1.03), less than Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (15.95), greater than Zhejiang Tailin BioEngineering Co.,Ltd (3.88), less than Tellgen Corporation (11.00), greater than Ningbo David Medical Device Co., Ltd. (4.06),

Build a custom stock screener for Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang Orient Gene Biotech Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zhejiang Orient Gene Biotech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.